Optimistic bias, advertising skepticism, and consumer intentions for seeking information about the health risks of prescription medicine

ABSTRACT

Based on a survey of prescription drug users (N = 408), this study revealed that: (a) the frequency of consumers’ personal experience of prescription medicine adverse reactions negatively related to the extent of their optimistic bias about the chances of such events, (b) consumers’ perceived personal control over adverse reactions positively related to optimistic bias, and (c) optimistic bias related more negatively to intentions to seek risk information when consumer skepticism toward direct-to-consumer advertising was high. When skepticism was low to average, optimistic bias did not inhibit such intentions. Implications and recommendations for the practice of direct-to-consumer advertising are provided.

KEYWORDS:

• Advertising skepticism
• direct-to-consumer prescription drug advertising
• DTCA
• optimistic bias
• risk disclosure